Professor Chi Jingxun’s Study On The Treatment Of Lower Extremity Arteriosclerosis Obliteration

Objective: Professor Chi Jingxun,as a national famous Chinese medicine expert,has profound knowledge of TCM surgery and has rich clinical experience in the diagnosis and treatment of lower extremity arteriosclerotic occlusive disease.This topic has passed the "Traditional Chinese Medicine Heritage Supporting Platform V2.5".To analyze the clinical syndrome differentiation and clinical experience of Professor Chi Jingxun for lower extremity arteriosclerotic occlusive disease,and to explore the academic characteristics of Professor Chi Jingxun.Methods: By collecting the cases of lower extremity arteriosclerotic occlusive disease treated by Professor Chi Jingxun from January 1,2013 to October 30,2018,using the "Traditional Chinese Medicine Supporting Platform V2.5" to analyze the syndrome differentiation of Professor Jing Jingxun.The frequency of drug use,the prescription of the prescription,and the analysis of the new party.Results: For 180 cases,149 prescription analysis,Professor Chi Jingxun in the treatment of lower extremity arteriosclerotic occlusive disease,the most frequently used drugs are blood stasis drugs,qi medicine and Qingreliangxue medicine,Most,followed by heart,spleen,kidney and so on.The top 10 drugs are: Angelica,Dilong,Chishao,Chuanxiong,Achyranthes,Peach,Spatholobus,Saffron,Licorice,and Astragalus.Get two new parties: safflower,medlar,forsythia,peach kernel,coix seed,Chuanxiong;angelica tail,angelica,eucommia,achyranthes,antler gum,rehmannia root.Conclusion: Professor Chi Jingxun has rich clinical experience in the treatment of lower extremity arteriosclerotic occlusive disease,which has important guiding significance for the treatment of this disease in the future.Through case analysis,Professor Chi Jingxun believes that in the pathogenesis of lower extremity arteriosclerotic occlusive disease,blood stasis runs through the course of the disease,and can be cold,wet,hot,and imaginary.At the same time,the treatment of blood circulation and blood stasis throughout the course of the disease,according to clinical symptoms and syndrome differentiation.